Literature DB >> 7980504

Chronic progressive external ophthalmoplegia is associated with a novel mutation in the mitochondrial tRNA(Asn) gene.

P Seibel1, J Lauber, T Klopstock, C Marsac, B Kadenbach, H Reichmann.   

Abstract

Chronic progressive external ophthalmoplegia (CPEO) is caused by a decreased oxidative phosphorylation (OXPHOS) activity due to large-scale deletions of the mitochondrial genome in 50% of the patients. The deletions encompass structural OXPHOS genes as well as tRNA genes, required for their expression so that the pathogenesis could be due to the deleted OXPHOS subunits or to an impaired mitochondrial translation. We have analyzed the mitochondrial genome of a patient presenting with CPEO for single base substitutions and discovered a novel heteroplasmic mutation in the tRNA(Asn) gene at position 5692 that converts a highly conserved adenine into a guanine. This mutation is unique because it is located at the transition of the anticodon loop to the anticodon stem and it leads to an additional base pair, thus reducing the number of loop-forming nucleotides from seven to five. Our findings suggest that CPEO can be caused by a single base substitution in a mitochondrial tRNA gene so that the mitochondrial protein synthesis becomes the rate limiting step in OXPHOS fidelity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7980504     DOI: 10.1006/bbrc.1994.2485

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

Review 1.  Clinical mitochondrial genetics.

Authors:  P F Chinnery; N Howell; R M Andrews; D M Turnbull
Journal:  J Med Genet       Date:  1999-06       Impact factor: 6.318

2.  A new mtDNA mutation showing accumulation with time and restriction to skeletal muscle.

Authors:  K Weber; J N Wilson; L Taylor; E Brierley; M A Johnson; D M Turnbull; L A Bindoff
Journal:  Am J Hum Genet       Date:  1997-02       Impact factor: 11.025

3.  Detection of mitochondrial defects by laser fluorimetry.

Authors:  W S Kunz; K Winkler; A V Kuznetsov; H Lins; E Kirches; C W Wallesch
Journal:  Mol Cell Biochem       Date:  1997-09       Impact factor: 3.396

4.  A novel mitochondrial tRNA(Val) T1658C mutation identified in a CPEO family.

Authors:  Naihong Yan; Shuping Cai; Bo Guo; Yi Mou; Jing Zhu; Jun Chen; Ting Zhang; Ronghua Li; Xuyang Liu
Journal:  Mol Vis       Date:  2010-08-25       Impact factor: 2.367

5.  The novel mitochondrial tRNAAsn gene mutation m.5709T>C produces ophthalmoparesis and respiratory impairment.

Authors:  Dario Ronchi; Monica Sciacco; Andreina Bordoni; Monika Raimondi; Michela Ripolone; Elisa Fassone; Alessio Di Fonzo; Mafalda Rizzuti; Patrizia Ciscato; Alessandra Cosi; Maura Servida; Maurizio Moggio; Stefania Corti; Nereo Bresolin; Giacomo P Comi
Journal:  Eur J Hum Genet       Date:  2011-12-21       Impact factor: 4.246

6.  Transfer RNA detection by small RNA deep sequencing and disease association with myelodysplastic syndromes.

Authors:  Yan Guo; Amma Bosompem; Sanjay Mohan; Begum Erdogan; Fei Ye; Kasey C Vickers; Quanhu Sheng; Shilin Zhao; Chung-I Li; Pei-Fang Su; Madan Jagasia; Stephen A Strickland; Elizabeth A Griffiths; Annette S Kim
Journal:  BMC Genomics       Date:  2015-09-24       Impact factor: 3.969

7.  Disclosing the functional changes of two genetic alterations in a patient with Chronic Progressive External Ophthalmoplegia: Report of the novel mtDNA m.7486G>A variant.

Authors:  Mafalda Bacalhau; Marta Simões; Mariana C Rocha; Steven A Hardy; Amy E Vincent; João Durães; Maria C Macário; Maria João Santos; Olinda Rebelo; Carla Lopes; João Pratas; Cândida Mendes; Mónica Zuzarte; A Cristina Rego; Henrique Girão; Lee-Jun C Wong; Robert W Taylor; Manuela Grazina
Journal:  Neuromuscul Disord       Date:  2017-11-23       Impact factor: 4.296

8.  Progressive external ophthalmoplegia associated with novel MT-TN mutations.

Authors:  Kittichate Visuttijai; Carola Hedberg-Oldfors; Ulrika Lindgren; Sara Nordström; Ólöf Elíasdóttir; Christopher Lindberg; Anders Oldfors
Journal:  Acta Neurol Scand       Date:  2020-09-19       Impact factor: 3.915

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.